IGF-1R signaling can prevent cancer cells from undergoing anoikis, a type of cell death that occurs when cells lose their attachment to the extracellular matrix and neighboring cells, possibly via inhibiting the activation of p53 and p21 [87]. The gene discussed is IGF1R; the disease is cancer.